The American College of Radiology (ACR) provided the White House with recommendations on regulating and monitoring AI technologies in clinical radiology.
Key Details
- 1ACR submitted feedback to the White House Office of Science and Technology Policy on AI integration in clinical settings.
- 2Key focus areas include AI oversight, reimbursement strategies, and government transparency.
- 3ACR stressed enhancing FDA oversight, especially for adaptive and continuous learning AI systems.
- 4They recommended real-world and post-market monitoring to address issues like AI model drift.
- 5ACR highlighted national AI registries such as Assess-AI for ongoing model performance tracking and data privacy concerns.
Why It Matters
These recommendations will help shape national policy around safe, effective, and transparent use of AI in radiology, directly impacting radiologists, vendors, and patients. Real-world tracking and better regulation are critical for trustworthy AI adoption in medical imaging.
Source
Radiology Business
Related News
•Radiology Business
Radiology Partners Urges FDA for Clarity on Imaging AI Regulations
Radiology Partners and Mosaic Clinical Technologies petition the FDA for clearer regulatory guidelines on imaging AI vision-language models.
•Radiology Business
FDA Solicits Public Input on Regulating Generative AI in Medical Devices
The FDA is seeking public feedback on how to regulate generative AI in medical devices, recognizing both its promise and risks.
•HealthExec
AI's Role in Eliminating Cervical Cancer: A Model for Disease Prevention
Researchers highlight how AI can accelerate the elimination of cervical cancer and set a precedent for combating other diseases.